Platinib R&D Process, Market Price and Purchasing Guidelines

Pralsetinib (Pralsetinib), known under the trade name Phuji Huawei, is a powerful and highly selective oral drug developed by Blueprint Medicines Corporation that targets oncogenic RET mutations. Variations in the RET gene are closely linked to the development of many malignant tumors, and Platinib effectively prevents the proliferation of cells expressing RET gene mutations by inhibiting the phosphorylation process of RET and its downstream molecules, thereby achieving anti-tumor effects.

1. R&D process

The development of Platinib is a journey of scientific exploration and challenges. Since the RET gene was first discovered in 1985, scientists have gradually revealed its key role in the development of cancer. However, early multi-kinase inhibitors did not achieve ideal results in the treatment of RET fusion non-small cell lung cancer. By constructing a library of compound molecules targeting kinases, Blueprint Medicines carefully screened out framework molecules suitable for transformation into RET-specific inhibitors. After a series of optimizations and transformations, Platinib was finally successfully developed.

2. Market price

The market selling price of platinib is affected by many factors, including drug sources, specifications, purchasing channels, and exchange rate fluctuations. In my country, the original drug platinib, jointly produced by Blueprint Medicines and China CStone Pharmaceuticals, costs about 20,000 to 30,000 yuan per box, and the specification is 100mg*120 tablets. In Laos, the price of generic drugs of Platinib is more affordable, with each box (100mg*120 pills) priced at about more than 4,000 yuan.

3. Purchase Guide

When purchasing platinib, patients should follow the following guidelines:

1. Choose formal channels: Patients should purchase Platinib through regular hospitals, pharmacies, online pharmacies or regular overseas medical institutions to ensure the authenticity and quality of the drug.

2. Dosage under the guidance of a doctor: Patients should use Platinib rationally under the guidance of a doctor and take it strictly in accordance with the doctor's instructions.

3. Possess a doctor’s prescription: When purchasing Platinib, patients need to hold a doctor’s prescription to prove the legality and necessity of the drug.

4. Pay attention to medical insurance and assistance: Patients can pay attention to medical insurance policies or drug assistance programs to reduce the pressure of treatment costs.

The successful development of platinib provides a new treatment option for patients with RET fusion-positive cancer, and its significant anti-tumor activity brings patients hope of extending survival. However, the high price is also one of the important factors that patients need to consider. By following these purchasing guidelines, patients can better manage the cost of treatment and ensure the authenticity and quality of their medicines.